Hans-Gerd Fieguth

Vanessa Neuhaus^*,1, 

Olga Danov^*,1, 

Sebastian Konzok¹, 

Helena Obernolte¹, 

Susann Dehmel¹, 

Peter Braubach², 

Danny Jonigk², 

Hans-Gerd Fieguth³, 

Patrick Zardo⁴, 

Gregor Warnecke⁴, 

Christian Martin⁵, 

Armin Braun^1,6, 

Katherina Sewald¹ 

¹Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of REBIRTH Cluster of Excellence, 

²Institute for Pathology, Hannover Medical School, German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), 

³Division of Thoracic and Vascular Surgery, Klinikum Region Hannover (KRH), 

⁴Department of Cardiothoracic, Transplantation and Vascular Surgery (HTTG), Hannover Medical School, German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), 

⁵Institute of Pharmacology and Toxicology, RWTH Aachen University, 

⁶Institute for Immunology, Hannover Medical School